Is Alliance For Clinical Trials In Oncology Foundation Legit?

Quick charity verification for Alliance For Clinical Trials In Oncology Foundation (EIN: 20464400)

Verdict: Alliance For Clinical Trials In Oncology Foundation appears trustworthy

90/100Mission Score
$68.0MRevenue
$112.8MAssets
1Red Flags
4Strengths

Red Flags

Strengths

Spending Breakdown

How Alliance For Clinical Trials In Oncology Foundation allocates its funds across programs, administration, and fundraising.

90%
Program Spending
Healthy — majority goes to mission
5%
Admin Costs
Reasonable — admin costs in check
5%
Fundraising
Within typical range
How to read this: Well-run charities typically spend 75% or more on programs, keep admin under 25%, and fundraising under 15%. A high program ratio means more of every dollar goes directly to the mission.

How to Interpret This Report

What Red Flags Mean

Red flags are potential warning signs identified by AI analysis of IRS 990 filings. They may indicate issues like declining revenue, high executive pay relative to program spending, lack of transparency, or governance concerns. A single red flag does not necessarily mean an organization is untrustworthy, but multiple flags warrant further investigation before donating.

What Mission Score Measures

The Mission Score (0-100) evaluates how effectively a nonprofit fulfills its stated purpose. It combines multiple factors: program spending efficiency (how much goes to programs vs. overhead), financial health and sustainability, governance quality, transparency in reporting, and consistency of operations over time. A score of 70+ indicates strong alignment with the organization’s mission.

Using This Data for Donation Decisions

Use this report as one input in your decision. Look at the overall Mission Score for a quick assessment, review red flags and strengths for specific concerns, check the spending breakdown to see where money goes, and compare executive compensation to the organization’s size. Consider viewing the full transparency report for deeper analysis, and always verify tax-exempt status with the IRS before making large donations.

Frequently Asked Questions about Alliance For Clinical Trials In Oncology Foundation

Is Alliance For Clinical Trials In Oncology Foundation a legitimate charity?

Based on AI analysis of IRS 990 filings, Alliance For Clinical Trials In Oncology Foundation (EIN: 20464400) appears trustworthy. Mission Score: 90/100. 1 red flag identified, 4 strengths noted.

Is Alliance For Clinical Trials In Oncology Foundation a good charity to donate to?

Alliance For Clinical Trials In Oncology Foundation has a Mission Score of 90/100. Revenue: $68.0M. Assets: $112.8M. Review the full transparency report for detailed spending breakdown and executive compensation analysis.

What is the EIN for Alliance For Clinical Trials In Oncology Foundation?

The Employer Identification Number (EIN) for Alliance For Clinical Trials In Oncology Foundation is 20464400. This is the unique tax ID assigned by the IRS.

What is a Mission Score?

The Mission Score is a 0-100 rating that measures how effectively a nonprofit fulfills its stated mission. It factors in program spending efficiency, financial transparency, governance practices, and outcome reporting. Scores above 70 indicate strong mission alignment, 40-69 suggest mixed performance, and below 40 signals potential concerns.

How does Alliance For Clinical Trials In Oncology Foundation spend its money?

Alliance For Clinical Trials In Oncology Foundation allocates 90% to programs, 5% to administration, and 5% to fundraising. Healthy nonprofits typically spend 75%+ on programs.

How can I verify Alliance For Clinical Trials In Oncology Foundation's tax-exempt status?

You can verify Alliance For Clinical Trials In Oncology Foundation's tax-exempt status using EIN 20464400 on the IRS Tax Exempt Organization Search (TEOS) at apps.irs.gov/app/eos. You can also request copies of their Form 990 directly from the organization, as they are required by law to provide them upon request.

AI Transparency Report

The Alliance For Clinical Trials In Oncology Foundation demonstrates consistent financial health, with revenues generally exceeding expenses over the past decade, contributing to a robust asset base. For instance, in 2023, revenue was $41,500,086 against expenses of $40,022,855, indicating a surplus. The organization's assets have grown significantly, from $53,800,530 in 2014 to $118,132,432 in 2023, suggesting strong financial management and capacity. Spending efficiency appears high, as the organization consistently reports 0% officer compensation, indicating that leadership is either unpaid or compensated through other means not categorized as officer compensation on the 990, which is a positive indicator for donor confidence. While a detailed breakdown of program, administrative, and fundraising expenses isn't provided in the summary data, the overall financial picture suggests a focus on mission-related activities given the consistent surpluses and asset growth. The absence of reported officer compensation also points to a lean operational structure at the top. Transparency is generally good, with a consistent history of 13 IRS 990 filings. The consistent reporting of 0% officer compensation is a notable transparency point, though further detail on how leadership is supported would provide even greater clarity. The organization's substantial assets relative to its annual expenses suggest long-term stability and the ability to fund its clinical trial initiatives effectively.

View Full Transparency Report →

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.

Related Pages